Cite
HARVARD Citation
Wang, L. et al. (n.d.). Bortezomib in combination with thalidomide or lenalidomide or doxorubicin regimens for the treatment of multiple myeloma: a meta-analysis of 14 randomized controlled trials. Leukemia & lymphoma. 55 (7), pp. 1479-1488. [Online].